11.70
+0.465(+4.14%)
Currency In USD
| Previous Close | 11.24 |
| Open | 11.86 |
| Day High | 12.16 |
| Day Low | 11.25 |
| 52-Week High | 55.89 |
| 52-Week Low | 5.2 |
| Volume | 270,582 |
| Average Volume | 318,266 |
| Market Cap | 110.18M |
| PE | -1.24 |
| EPS | -9.42 |
| Moving Average 50 Days | 9.45 |
| Moving Average 200 Days | 19.13 |
| Change | 0.47 |
If you invested $1000 in Korro Bio, Inc. (KRRO) since IPO date, it would be worth $17.08 as of February 20, 2026 at a share price of $11.7. Whereas If you bought $1000 worth of Korro Bio, Inc. (KRRO) shares 5 years ago, it would be worth $4.49 as of February 20, 2026 at a share price of $11.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Korro to Host Virtual Analyst Day on January 27, 2026
GlobeNewswire Inc.
Jan 20, 2026 1:00 PM GMT
- Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia, a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 08, 2026 1:00 PM GMT
CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday,
Korro to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire Inc.
Sep 02, 2025 8:30 PM GMT
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's